Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE Highlights
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The development of personalized neoantigen peptide vaccines will specifically and effectively target cancer cells in individuals, opening a new door for cancer immunotherapy. Creative Biolabs has cGMP-certified production facilities and expertise that enable us to produce non-GMP and GMP grade peptides. Using state-of-the-art equipment and an experienced team with the latest technology, Creative Biolabs' comprehensive range of high-quality peptide synthesis services includes customized peptide synthesis, high-throughput peptide libraries, and peptide array services.
Creative Biolabs' GMP manufacturing facilities are designed in strict accordance with the FDA's GMP manufacturing guidelines. We produce peptides up to 50 amino acids in length ranging from grams to kilograms. Our manufacturing capabilities are designed to meet the needs of our customers:
For more details, please feel free to contact us for project quotations and more detailed information.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
Small Molecular Drug Discovery
Antibody Generation
Vaccine Development